
A monitoring committee policy was established by the Southwest Oncology Group in 1985 to address documented problems in study zzso Committees consisting of the study zzso disease committee chair, study zzso Group chair, Group zzso an zzso Southwest Oncology Group clinician, an zzso zzso and a representative from each involved group for intergroup studies have been appointed for each phase III zzso Business is conducted largely through the mail and through conference zzso Since then, problems identified in older studies have been largely zzso zzso and timely decisions are being made at modest additional expense to the zzso 

